申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20150322044A1
公开(公告)日:2015-11-12
The present invention provides compounds of Formula (I):
or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, or a solvate thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medicaments.
本发明提供了式(I)的化合物:或其立体异构体、互变异构体、药学上可接受的盐、多晶形或溶剂化物,其中所有变量的定义如本文所述。这些化合物是GPR40 G蛋白偶联受体调节剂,可用作药物。